MYD88 and severe acute respiratory syndrome: Contrary to previous virological studies [16]–[19],[21],[39], we have demonstrated MyD88 plays a crucial role in protection from SARS-CoV infection independent of Type I (α/β) and III (IL-28/29 or interferon lambda) interferon, and the adaptive immune response.